Cong Bang Truong (Bang Truong)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 21

Top Topics

Atrial Fibrillation

Advanced Cancer

Papillary Thyroid

Drug Administration

Top Venues

Journal of thrombosis and thrombolysis

Cardiovascular toxicology

Dermatology and therapy

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Cong Bang Truong, Lori Hornsby, Brent Fox, Chiahung Chou, Jingyi Zheng, Jingjing Qian
Benefit and risk of oral anticoagulant initiation strategies in patients with atrial fibrillation and cancer: a target trial emulation using the SEER-Medicare database. Journal of thrombosis and thrombolysis 57 (4) (2024)
Andreas Pinter, Ahmed M Soliman, Irina Pivneva, Roksana Ghanbariamin, Min Yang, Cong Bang Truong, Lluis L Puig, Mark Lebwohl
Real-World Long-Term Effectiveness of Risankizumab Among Patients with Moderate-to-Severe Psoriasis: Analysis from an International Medical Chart Review (RAPID) Study. Dermatology and therapy 14 (5) (2024)
Cong Bang Truong, Lori Hornsby, Brent Fox, Chiahung Chou, Jingyi Zheng, Jingjing Qian
Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation and Cancer: A Target Trial Emulation from SEER-Medicare Database. Cardiovascular drugs and therapy (2024)
Cong Bang Truong, Jingyi Zheng, Lori Hornsby, Brent Fox, Chiahung Chou, Jingjing Qian
Development and Validation of Machine Learning Algorithms to Predict 1-Year Ischemic Stroke and Bleeding Events in Patients with Atrial Fibrillation and Cancer. Cardiovascular toxicology 24 (4) (2024)
Andreas Pinter, Ahmed M Soliman, Irina Pivneva, Roksana Ghanbariamin, Min Yang, Cong Bang Truong, Lluis L Puig, Mark Lebwohl
Real-World Long-Term Effectiveness of Risankizumab Among Patients with Moderate-to-Severe Psoriasis: Analysis from an International Medical Chart Review (RAPID) Study. Dermatology and therapy 14 (5) (2024)
Cong Bang Truong, Lori Hornsby, Brent Fox, Chiahung Chou, Jingyi Zheng, Jingjing Qian
Benefit and risk of oral anticoagulant initiation strategies in patients with atrial fibrillation and cancer: a target trial emulation using the SEER-Medicare database. Journal of thrombosis and thrombolysis (2024)
Cong Bang Truong, Lori Hornsby, Brent Fox, Chiahung Chou, Jingyi Zheng, Jingjing Qian
Benefit and risk of oral anticoagulant initiation strategies in patients with atrial fibrillation and cancer: a target trial emulation using the SEER-Medicare database. Journal of thrombosis and thrombolysis 57 (4) (2024)
Cong Bang Truong, Lori Hornsby, Brent Fox, Chiahung Chou, Jingyi Zheng, Jingjing Qian
Benefit and risk of oral anticoagulant initiation strategies in patients with atrial fibrillation and cancer: a target trial emulation using the SEER-Medicare database. Journal of thrombosis and thrombolysis 57 (4) (2024)
Cong Bang Truong, Lori Hornsby, Brent Fox, Chiahung Chou, Jingyi Zheng, Jingjing Qian
Benefit and risk of oral anticoagulant initiation strategies in patients with atrial fibrillation and cancer: a target trial emulation using the SEER-Medicare database. Journal of thrombosis and thrombolysis 57 (4) (2024)
Andreas Pinter, Ahmed M Soliman, Irina Pivneva, Roksana Ghanbariamin, Min Yang, Cong Bang Truong, Lluis L Puig, Mark Lebwohl
Real-World Long-Term Effectiveness of Risankizumab Among Patients with Moderate-to-Severe Psoriasis: Analysis from an International Medical Chart Review (RAPID) Study. Dermatology and therapy (2024)
Cong Bang Truong, Jingyi Zheng, Lori Hornsby, Brent Fox, Chiahung Chou, Jingjing Qian
Development and Validation of Machine Learning Algorithms to Predict 1-Year Ischemic Stroke and Bleeding Events in Patients with Atrial Fibrillation and Cancer. Cardiovascular toxicology 24 (4) (2024)
Cong Bang Truong, Jingyi Zheng, Lori Hornsby, Brent Fox, Chiahung Chou, Jingjing Qian
Development and Validation of Machine Learning Algorithms to Predict 1-Year Ischemic Stroke and Bleeding Events in Patients with Atrial Fibrillation and Cancer. Cardiovascular toxicology (2024)
Cong Bang Truong, Jingyi Zheng, Lori Hornsby, Brent Fox, Chiahung Chou, Jingjing Qian
Development and Validation of Machine Learning Algorithms to Predict 1-Year Ischemic Stroke and Bleeding Events in Patients with Atrial Fibrillation and Cancer. Cardiovascular toxicology 24 (4) (2024)
Cong Bang Truong, Lori Hornsby, Brent Fox, Chiahung Chou, Jingyi Zheng, Jingjing Qian
Benefit and risk of oral anticoagulant initiation strategies in patients with atrial fibrillation and cancer: a target trial emulation using the SEER-Medicare database. Journal of thrombosis and thrombolysis 57 (4) (2024)
Andreas Pinter, Ahmed M Soliman, Irina Pivneva, Roksana Ghanbariamin, Min Yang, Cong Bang Truong, Lluis L Puig, Mark Lebwohl
Real-World Long-Term Effectiveness of Risankizumab Among Patients with Moderate-to-Severe Psoriasis: Analysis from an International Medical Chart Review (RAPID) Study. Dermatology and therapy 14 (5) (2024)
Xiangzhong Xue, Cong Bang Truong, Jingjing Qian
Adverse event reporting of marketed biosimilar and biological monoclonal antibody cancer treatments in the United States. Expert opinion on biological therapy (2023)
Cong Bang Truong, Lori Hornsby, Brent I Fox, Chiahung Chou, Jingyi Zheng, Jingjing Qian
Screening for clinically relevant drug-drug interactions between direct oral anticoagulants and antineoplastic agents: a pharmacovigilance approach. Journal of thrombosis and thrombolysis (2023)
Phuong T Tran, Munaza Riaz, Ziyan Chen, Cong Bang Truong, Vakaramoko Diaby
An Umbrella Review of the Cost Effectiveness of Human Papillomavirus Vaccines. Clinical drug investigation 42 (5) (2022)
Kaniz Afroz Tanni, Cong Bang Truong, Sura Almahasis, Jingjing Qian
Safety of Marketed Cancer Supportive Care Biosimilars in the US: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 35 (2) (2021)
Cong Bang Truong, Spencer H Durham, Jingjing Qian
Comparisons of adverse event reporting for colistin versus polymyxin B using the US Food and Drug Administration Adverse Event Reporting System (FAERS). Expert opinion on drug safety 20 (5) (2021)
Jingjing Qian, Cong Bang Truong, Kaniz Afroz Tanni
Author's Reply to Joerg Putzke et al. Comment on: "Safety of Marketed Cancer Supportive Care Biosimilars in the US: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database". BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 35 (3) (2021)